Healthcare

Filter by: collapse

By Relevance

By Asc Time
By Desc Time

Company

Micro-Tech
Bloomage
Haohai
Fudan-Zhangjiang
Ali Health
Aier Eye Hospital
Topchoice Medical
DAZD
Lepu Medical
Fosun Pharma
Yuyue
Jointown Pharmaceutical
Huiyihuiying
Burning Rock
InferVision
VoxelCloud
Berry Genomics
Mindray
United Imaging
12Sigma
WuXi AppTec
Henlius
Tigermed
BeiGene
Miao Shou Doctor
ZFSW
Buchang Pharmaceutical
CSPC
Yucebio
I-Mab Bio
HaoDF Online
Shcell
Taimei
Tencent Trusted Doctors
Medlinker
Ping An Good Doctor
Meinian Onehealth
Tong Ren Tang
Winning
BGI Genomics
Hengrui Medicine
Tasly
Yunnan Baiyao
JD Healthcare
Gengmei
Jacobiopharma
Medtrum
Yaxin Medical
DXY

Author

Yuanpu Huang
Linyan Feng
Fan Zhang
Yingwei Fu
Tang Shiyu
Li Jia
Tang Shiyu
Xie Xin
Li Jia
Qasim Khan
Wang Zekun
Annie Chen
An Feng
Yusuf I. Tuna
Sylvia Liang
Butao Wang
Shang Yang
Ivan Platonov
Zhou Sirui
Zhou Huiting
Cao Wenbo
Qiu Yuxian
WIM Committee
Aysen Sutakov
Huicong Yi
Bo Chunmin
Gilson Tavares
Zhenglei Shi
Edison Mulia
Shuhong Chenli
Gozde Celik
Chendi Qian
Yizhou Gu
Li Tianqi
Mengyao Zhang
Yue Liu
Dixuan Lu
Xiangyu Zhang
Beier Kan
Chao Gong
Contributor
Bob Wang

by Mengyao Zhang Updated 5 hours ago

Report: Medical Devices Made in China

The Chinese medical device industry is catching up in an unstoppable manner.

by Mengyao Zhang Updated 5 hours ago

Healthcare

Report: Medical Devices Made in China

by Mengyao Zhang Updated 5 hours ago

by Mengyao Zhang Jul 31, 2020 10:36 am

WeDoctor Postpones Hong Kong IPO to 2021

The IPO hints started showing up in May 2018 and seem to be going strong this year.

by Mengyao Zhang Jul 31, 2020 10:36 am

Healthcare

WeDoctor Postpones Hong Kong IPO to 2021

by Mengyao Zhang Jul 31, 2020 10:36 am

by Mengyao Zhang Jul 30, 2020 01:43 pm

Ophthalmic Device Maker Eyebright's Price Rises over 500% on IPO

Eyebright (688050) landed on the Chinese Nasdaq as the first ophthalmic device maker.

by Mengyao Zhang Jul 30, 2020 01:43 pm

Healthcare

Ophthalmic Device Maker Eyebright's Price Rises over 500% on IPO

by Mengyao Zhang Jul 30, 2020 01:43 pm

by Mengyao Zhang Jul 28, 2020 11:48 am

Hillhouse’s GL VC Leads Brosmed’s Series C to Long Chinese Medical Devices

Brosmed is the first medical device company that Hillhouse’s GL Ventures has invested in since the latter's inception this year.

by Mengyao Zhang Jul 28, 2020 11:48 am

Healthcare

Hillhouse’s GL VC Leads Brosmed’s Series C to Long Chinese Medical Devices

by Mengyao Zhang Jul 28, 2020 11:48 am

by Mengyao Zhang Jul 24, 2020 05:26 pm

JD Health Eyes Hong Kong IPO for USD 1 Bn

JD’s third unicorn was valued at USD 7 billion after a Series A fundraising in November 2019.

by Mengyao Zhang Jul 24, 2020 05:26 pm

Healthcare

JD Health Eyes Hong Kong IPO for USD 1 Bn

by Mengyao Zhang Jul 24, 2020 05:26 pm

by Mengyao Zhang Jul 23, 2020 10:58 am

Ali Health Helps Accelerate Home Healthcare Cofoe’s IPO Process

The COVID-19 pandemic is boosting sales of home-use medical devices.

by Mengyao Zhang Jul 23, 2020 10:58 am

Healthcare

Ali Health Helps Accelerate Home Healthcare Cofoe’s IPO Process

by Mengyao Zhang Jul 23, 2020 10:58 am

by Mengyao Zhang Jul 22, 2020 11:53 am

Tong Ren Tang: Any Hope for this Purveyor of Centuries-Old Chinese Medicines?

Since the biotechnology pharmaceutical scene has become a red ocean, attracting new entrants and capital, TCM players are encountering some harsh new realities.

by Mengyao Zhang Jul 22, 2020 11:53 am

Healthcare

Tong Ren Tang: Any Hope for this Purveyor of Centuries-Old Chinese Medicines?

by Mengyao Zhang Jul 22, 2020 11:53 am

by Mengyao Zhang Jul 21, 2020 01:40 pm

In-Licensing Service Everest Medicines Eyes HK IPO after USD 300 Mn Series C

Not long after a Series C fundraising in June this year, Everest Medicine initiated a public listing, marking a further strategic move for the biotech firm.

by Mengyao Zhang Jul 21, 2020 01:40 pm

Healthcare

In-Licensing Service Everest Medicines Eyes HK IPO after USD 300 Mn Series C

by Mengyao Zhang Jul 21, 2020 01:40 pm

EqualOcean is an international information service provider and investment research firm that aims to become a global platform for industrial innovation.

We strive to make technology inclusive, accessible and transparent.

Join over 70,000 of your peers

Address

Beijing

9 Xiaguangli, 10F Block A CEC Development Mansion, Chaoyang Dc, Beijing 100125, China

Shanghai

A002, 5F, Ai Tower, 701 Yunjin Road, Xuhui Dc, Shanghai 200232, China

New York

800 Third Ave, 28F, New York, NY 10022, USA

About

Careers

Principles

Team

Interviews with analysts

Cooperation with customers

Cooperation strategy

Products & prices

Customers & evaluation

Experience news with our apps